These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37355392)

  • 121. A commentary on "Health-related quality of life trajectories up to 15 years after curative treatment for esophageal cancer: a prospective cohort study".
    Ji H; Yang L; Li W
    Int J Surg; 2024 Apr; ():. PubMed ID: 38661559
    [No Abstract]   [Full Text] [Related]  

  • 122. The Expression of TP63 as a Biomarker of Early Recurrence in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy.
    Lin CH; Cheng PL; Chuang CY; Kang YT; Lee LW; Hsiao TH; Hsu CP
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38791062
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Prognostic value of Mandard score and nodal status for recurrence patterns and survival after multimodal treatment of oesophageal adenocarcinoma.
    Henckens SPG; Liu D; Gisbertz SS; Kalff MC; Anderegg MCJ; Crull D; Daams F; van Dalsen AD; Dekker JWT; van Det MJ; van Duijvendijk P; Eshuis WJ; Groenendijk RPR; Haveman JW; van Hillegersberg R; Luyer MDP; Olthof PB; Pierie JEN; Plat VD; Rosman C; Ruurda JP; van Sandick JW; Sosef MN; Voeten DM; Vijgen GHEJ; Bijlsma MF; Meijer SL; Hulshof MCCM; Oyarce C; Lagarde SM; van Laarhoven HWM; van Berge Henegouwen MI;
    Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38387083
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
    Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Impact of radial margins after esophagectomy for esophageal cancer.
    Bravo-Iñiguez CE; He Z; Dezube AR; Mazzola E; Yelamanchili N; Zhao L; Bueno R; Swanson SJ; White A; Wiener DC; Jaklitsch MT; Wee JO
    Eur J Surg Oncol; 2021 Sep; 47(9):2313-2322. PubMed ID: 33714649
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
    Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
    Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Locoregional Recurrence of Esophageal Cancer Treated with Curative Intent Local Salvage Therapy: A Single Center Experience.
    Grou-Boileau F; Tankel J; Nevo Y; Najmeh S; Spicer J; Cools-Lartigue J; Mueller C; Ferri L
    J Gastrointest Cancer; 2023 Dec; 54(4):1292-1299. PubMed ID: 36988820
    [TBL] [Abstract][Full Text] [Related]  

  • 128. The effect of anastomotic leakage on the incidence of recurrence after tri-modality therapy for esophageal adenocarcinomas.
    Stam WT; Schuring N; Hulshof M; van Laarhoven H; Derks S; van Berge Henegouwen MI; van der Peet DL; Gisbertz SS; Daams F
    J Surg Oncol; 2023 Aug; 128(2):218-230. PubMed ID: 37133757
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Patterns of recurrent disease after neoadjuvant chemoradiotherapy and esophageal cancer surgery with curative intent in a tertiary referral center.
    Schuring N; Stam WT; Plat VD; Kalff MC; Hulshof MCCM; van Laarhoven HWM; Derks S; van der Peet DL; van Berge Henegouwen MI; Daams F; Gisbertz SS
    Eur J Surg Oncol; 2023 Oct; 49(10):106947. PubMed ID: 37355392
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Patterns of failure after salvage chemoradiotherapy for postoperative loco-regional recurrent esophageal cancer: 20-year experience in a single institution in Japan.
    Jingu K; Umezawa R; Yamamoto T; Takahashi N; Takeda K; Suzuki Y; Kishida K; Omata S; Sato Y; Kadoya N
    Esophagus; 2022 Oct; 19(4):639-644. PubMed ID: 35575821
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Chemoradiotherapy versus chemoradiotherapy plus surgery for esophageal cancer.
    Vellayappan BA; Soon YY; Ku GY; Leong CN; Lu JJ; Tey JC
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010511. PubMed ID: 28829911
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma.
    Lv J; Cao XF; Zhu B; Ji L; Tao L; Wang DD
    World J Gastroenterol; 2009 Oct; 15(39):4962-8. PubMed ID: 19842230
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Comparison of esophageal cancer survival after neoadjuvant chemoradiotherapy plus surgery versus definitive chemoradiotherapy: A systematic review and meta-analysis.
    Ke J; Xie Y; Huang S; Wang W; Zhao Z; Lin W
    Asian J Surg; 2024 Mar; ():. PubMed ID: 38448293
    [TBL] [Abstract][Full Text] [Related]  

  • 134.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 135.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 136.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 137.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 138.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 139.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.